Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates
In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…
CertaraMay 10, 2024
CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA
Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …
CertaraMay 10, 2024
How one university overcame practical and cultural challenges to implement CDISC compliance
A US-based university with a nationally recognized academic health center implemented Clinical Data Interchange Standards…
CertaraMay 8, 2024
CERTAINTY – Japan
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
CertaraMay 7, 2024
CERTAINTY – China
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…
CertaraMay 7, 2024
CERTAINTY – South Korea
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
CertaraMay 7, 2024
Certara Reports First Quarter 2024 Financial Result
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. (Nasdaq: CERT), a…
CertaraMay 7, 2024
